CEO and Chairman of Adaptive Biotechnologies Corp (30-Year Financial, Insider Trades) Chad M Robins (insider trades) sold 15,000 shares of ADPT on 04/08/2021 at an average price of $41.81 a share. The total sale was $627,150.
Adaptive Biotechnologies Corp has a market cap of $5.63 billion; its shares were traded at around $40.420000 with and P/S ratio of 54.10.
CEO Recent Trades:
- CEO and Chairman Chad M Robins sold 15,000 shares of ADPT stock on 04/08/2021 at the average price of $41.81. The price of the stock has decreased by 3.32% since.
- CEO and Chairman Chad M Robins sold 15,000 shares of ADPT stock on 03/19/2021 at the average price of $42.89. The price of the stock has decreased by 5.76% since.
CFO Recent Trades:
- CFO Chad M Cohen sold 20,000 shares of ADPT stock on 04/07/2021 at the average price of $41.3. The price of the stock has decreased by 2.13% since.
Directors and Officers Recent Trades:
- COO R Mark Adams sold 3,586 shares of ADPT stock on 04/07/2021 at the average price of $42.34. The price of the stock has decreased by 4.53% since.
- SVP and General Counsel Stacy L Taylor sold 4,167 shares of ADPT stock on 03/31/2021 at the average price of $40. The price of the stock has increased by 1.05% since.
- Chief Scientific Officer Harlan S Robins sold 19,475 shares of ADPT stock on 03/25/2021 at the average price of $40.36. The price of the stock has increased by 0.15% since.
- SVP, Diagnostics, immunoSEQ Dx Jyoti Palaniappan sold 16,052 shares of ADPT stock on 03/18/2021 at the average price of $43.58. The price of the stock has decreased by 7.25% since.
- Director Michelle Renee Griffin sold 6,000 shares of ADPT stock on 03/16/2021 at the average price of $43.06. The price of the stock has decreased by 6.13% since.
For the complete insider trading history of ADPT, click here
.
